IPSEN PHARMA

Ipsen Pharma is a global specialty-driven biopharmaceutical group focused on innovation and the development of solutions for unmet medical needs in the fields of oncology, neuroscience and rare diseases. Its commitment to oncology is highlighted by its growing portfolio of key therapies for prostate cancer, neuroendocrine tumors, bladder cancer and kidney cancer. Ipsen also has a strong presence in the central nervous system and rare disease markets. With total sales over €2.5 billion in 2021, Ipsen sells more than 20 drugs in over 115 countries, and its total workforce of close to 6,000 people is based in more than 30 countries worldwide. Ipsen's research and development efforts are focused on its innovative and differentiated technological platforms located in the heart of the leading biotechnological and life sciences hubs (Paris-Saclay, France; Oxford, UK; Cambridge, US).

Drugs and Druggists' Sundries Merchant Wholesalers; Drugs and Druggists' Sundries Merchant Wholesalers; Merchant Wholesalers, Nondurable Goods; Wholesale Trade

Drugs, Proprietaries, and Sundries; Wholesale Trade-Nondurable Goods; Wholesale Trade-Durable Goods; Wholesale Trade-Nondurable Goods

$2119.24M